Table 3 Spearman’s rho correlation between plasma p-Tau217 levels and neuropsychological tests scores in AD and non-AD group.

From: Promising clinical tools for specific Alzheimer disease diagnosis from plasma pTau217 and ApoE genotype in a cognitive disorder unit

 

AD

Non-AD

Plasma p-Tau217 (pg mL−1)

Rho (p value)

Plasma p-Tau217 (pg mL−1)

Rho (p value)

MMSE

− 0.37 (< 0.001*)

− 0.26 (0.003*)

CDR total scale

0.154 (> 0.05)

0.135 (> 0.05)

CDR sum of boxes

0.155 (> 0.05)

0.097 (> 0.05)

RBANS_IM

− 0.422 (< 0.001*)

− 0.144 (> 0.05)

RBANS_V/C

− 0.159 (> 0.05)

− 0.201 (< 0.03*)

RBANS_L

− 0.275 (< 0.001*)

− 0.174 (< 0.05*)

RBANS_A

− 0.187 (< 0.04*)

− 0.054 (> 0.05)

RBANS_DM

− 0.318 (< 0.001*)

− 0.225 (0.01*)

FAQ

0.140 (> 0.05)

0.23 (0.008*)

ADCS_ADL_MCI

− 0.164 (> 0.05)

− 0.279 (0.001*)

GDS

− 0.242 (0.006*)

− 0.157 (> 0.05)

  1. *P < 0.05.
Back to article page